The Madras High Court has issued a notice to the central government over a petition to declare the Pune-based Serum Institute of India's "Covishield" unsafe. The petition was filed by a 41-year-old man from Chennai who was a volunteer for the third phase of the Covid vaccine trial and was administered a dose on October 1. He had alleged adverse effects from the vaccine trials, claiming "loss of creativity and business". | NDTV

Parents of the woman who allegedly died after taking Covishield have decided to file a case against Serum Institute of India (SII), a day after AstraZeneca, which sold the vaccine in India, admitted in court that their Covid shot can cause a rare side effect. Nabila Jamal tells us more. #Covishield #SerumInstitute #AstraZeneca #SocialMediaSpecial #Unmissable | India Today